Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria

Risk Factors for Treatment Failure of Polymyxin B Monotherapy for Carbapenem-Resistant Klebsiella pneumoniae Infections

(2013) Yanina Dubrovskaya et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Does the Piperacillin Minimum Inhibitory Concentration for Pseudomonas aeruginosa Influence Clinical Outcomes of Children With Pseudomonal Bacteremia?

(2012) P. D. Tamma et al.   CLINICAL INFECTIOUS DISEASES

Association Between Colistin Dose and Microbiologic Outcomes in Patients With Multidrug-Resistant Gram-Negative Bacteremia

(2012) Giulia Vicari et al.   CLINICAL INFECTIOUS DISEASES

Pharmacokinetics and pharmacodynamics of ‘old’ polymyxins: what is new?

(2012) Phillip J. Bergen et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Colistin: an update on the antibiotic of the 21st century

(2012) Silpak Biswas et al.   Expert Review of Anti-Infective Therapy

Impact of vancomycin minimum inhibitory concentration on clinical outcomes of patients with vancomycin-susceptible Staphylococcus aureus infections: a meta-analysis and meta-regression

(2012) Michael N. Mavros et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis

(2012) Jesse T. Jacob et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment?

(2012) Gamze Kalin et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Clinical and microbiological efficacy and toxicity of colistin in patients infected with multidrug-resistant gram-negative pathogens

(2012) Gül R. Yılmaz et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients

(2011) S. M. Garonzik et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients

(2011) F. Kontopidou et al.   CLINICAL MICROBIOLOGY AND INFECTION

Colistin therapy in critically ill patients with chronic renal failure and its effect on development of renal dysfunction

(2011) Melda Turkoglu et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing

(2010) Lauren M Lim et al.   PHARMACOTHERAPY

Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients

(2009) Matthew E. Falagas et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES